Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANJANI D NARRA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1285795716
CMS profile
827536
Location
BATON ROUGE, LA

General Payments · PY2018–2024

$3,354.12

  • Reported across 180 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$686.05

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $686.05 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Indivior Inc. $194.95 11
Neurocrine BioSciences, Inc. $114.54 4
Teva Pharmaceuticals USA, Inc. $112.12 5
ITI, Inc. $69.82 4
ABBVIE INC. $67.26 4
Alkermes, Inc. $46.13 2
Braeburn Inc. $45.02 2
Otsuka America Pharmaceutical, Inc. $19.16 1
E.R. Squibb & Sons, L.L.C. $17.05 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $330.45 20
PY2019 $473.79 31
PY2020 $171.59 9
PY2021 $402.05 23
PY2022 $545.14 27
PY2023 $745.05 36
PY2024 $686.05 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.98 01/10/2024 Food and Beverage Undisputed 01/23/2026 1105100445 CMS
ABBVIE INC. $17.05 02/05/2024 Food and Beverage Undisputed 01/23/2026 1105100447 CMS
ABBVIE INC. $17.91 07/10/2024 Food and Beverage Undisputed 01/23/2026 1105100449 CMS
ABBVIE INC. $15.32 10/09/2024 Food and Beverage Undisputed 01/23/2026 1105100451 CMS
Alkermes, Inc. $21.30 04/17/2024 Food and Beverage Undisputed 01/23/2026 1120561274 CMS
Alkermes, Inc. $24.83 12/04/2024 Food and Beverage Undisputed 01/23/2026 1120561276 CMS
Braeburn Inc. $21.90 05/01/2024 Food and Beverage Undisputed 01/23/2026 1125599021 CMS
Braeburn Inc. $23.12 09/18/2024 Food and Beverage Undisputed 01/23/2026 1125599023 CMS
E.R. Squibb & Sons, L.L.C. $17.05 11/20/2024 Food and Beverage Undisputed 01/23/2026 1101250185 CMS
Indivior Inc. $19.11 01/23/2024 Food and Beverage Undisputed 01/23/2026 1144534219 CMS
Indivior Inc. $19.11 02/26/2024 Food and Beverage Undisputed 01/23/2026 1144534221 CMS
Indivior Inc. $8.95 02/28/2024 Food and Beverage Undisputed 01/23/2026 1144534223 CMS
Indivior Inc. $19.11 03/28/2024 Food and Beverage Undisputed 01/23/2026 1144534225 CMS
Indivior Inc. $19.11 04/15/2024 Food and Beverage Undisputed 01/23/2026 1144534227 CMS
Indivior Inc. $8.91 05/08/2024 Food and Beverage Undisputed 01/23/2026 1144534229 CMS
Indivior Inc. $27.95 05/21/2024 Food and Beverage Undisputed 01/23/2026 1144534231 CMS
Indivior Inc. $11.80 05/29/2024 Food and Beverage Undisputed 01/23/2026 1144534233 CMS
Indivior Inc. $25.59 06/17/2024 Food and Beverage Undisputed 01/23/2026 1144534235 CMS
Indivior Inc. $19.37 06/26/2024 Food and Beverage Undisputed 01/23/2026 1144534237 CMS
Indivior Inc. $15.94 12/18/2024 Food and Beverage Undisputed 01/23/2026 1144534239 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.64 04/03/2024 Food and Beverage Undisputed 01/23/2026 1143284365 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.63 05/08/2024 Food and Beverage Undisputed 01/23/2026 1143284368 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.40 05/28/2024 Food and Beverage Undisputed 01/23/2026 1143284372 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.15 10/16/2024 Food and Beverage Undisputed 01/23/2026 1143284376 CMS
Neurocrine Biosciences, Inc. $30.98 06/12/2024 Food and Beverage Undisputed 01/23/2026 1150824376 CMS
Neurocrine Biosciences, Inc. $25.39 08/22/2024 Food and Beverage Undisputed 01/23/2026 1150838788 CMS
Neurocrine Biosciences, Inc. $28.45 09/04/2024 Food and Beverage Undisputed 01/23/2026 1150829590 CMS
Neurocrine Biosciences, Inc. $29.72 10/02/2024 Food and Beverage Undisputed 01/23/2026 1150826434 CMS
Otsuka America Pharmaceutical, Inc. $19.16 05/22/2024 Food and Beverage Undisputed 01/23/2026 1118948822 CMS
Teva Pharmaceuticals USA, Inc. $26.29 01/24/2024 Food and Beverage Undisputed 01/23/2026 1151738071 CMS
Teva Pharmaceuticals USA, Inc. $22.41 03/13/2024 Food and Beverage Undisputed 01/23/2026 1151738083 CMS
Teva Pharmaceuticals USA, Inc. $23.40 03/27/2024 Food and Beverage Undisputed 01/23/2026 1151738099 CMS
Teva Pharmaceuticals USA, Inc. $23.16 04/11/2024 Food and Beverage Undisputed 01/23/2026 1151738101 CMS
Teva Pharmaceuticals USA, Inc. $16.86 07/31/2024 Food and Beverage Undisputed 01/23/2026 1151738173 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.